Equity Analysis

Quarterly Results

    Divis Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    532488
    INE361B01024
    513.6236355
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DIVISLAB
    86.67
    159224.07
    EPS(TTM)
    Face Value()
    Div & Yield %:
    69.2
    2
    0.5
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales2302.002063.002259.00
Other Operating Income0.000.000.00
Other Income 105.0079.0079.00
Total Income2407.002142.002338.00
Total Expenditure 1573.001442.001542.00
PBIDT834.00700.00796.00
Interest 1.000.002.00
PBDT833.00700.00794.00
Depreciation98.0097.0094.00
Tax218.00178.00159.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.00-5.0010.00
Reported Profit After Tax518.00430.00531.00
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item518.00430.00531.00
EPS (Unit Curr.)19.5116.1819.99
EPS (Adj) (Unit Curr.)19.5116.1819.99
Calculated EPS (Unit Curr.)19.5516.2320.04
Calculated EPS (Adj) (Unit Curr.)19.5516.2320.04
Calculated EPS (Ann.) (Unit Curr.)78.1964.9180.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)78.1964.9180.15
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity53.0053.0053.00
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)36.2333.9335.24
PBDTM(%)36.1933.9335.15
PATM(%)22.5020.8423.51
Dividend Per Share(Rs)0.000.000.00
Diluted EPS19.5116.1819.99